XML 29 R13.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY
 6 Months Ended
Mar. 29, 2025
Equity [Abstract]  
EQUITY (DEFICIT)
The following tables provide a summary of the changes in equity (deficit) for each of the periods indicated:
 Common Shares
and Capital in
Excess of Stated
Value		Retained
Earnings		Treasury
Shares		Accumulated Other
Comprehensive Loss		Total
Equity
(Deficit)
Balance at September 30, 2024$362.0 $303.8 $(949.1)$(107.3)$(390.6)
Net income (loss)— (69.5)— — (69.5)
Other comprehensive income (loss)— — — 2.5 2.5 
Share-based compensation31.4 — — — 31.4 
Dividends declared ($0.66 per share)
— (38.5)— — (38.5)
Treasury share purchases— — (15.6)— (15.6)
Treasury share issuances(44.3)— 45.1 — 0.8 
Balance at December 28, 2024349.1 195.8 (919.6)(104.8)(479.5)
Net income (loss)— 217.5 — — 217.5 
Other comprehensive income (loss)— — — (4.0)(4.0)
Share-based compensation8.7 — — — 8.7 
Dividends declared ($0.66 per share)
— (39.6)— — (39.6)
Treasury share purchases— — (2.7)— (2.7)
Treasury share issuances(14.5)— 23.9 — 9.4 
Balance at March 29, 2025$343.4 $373.7 $(898.4)$(108.8)$(290.1)
The sum of the components may not equal due to rounding.

 Common Shares
and Capital in
Excess of Stated
Value		Retained
Earnings		Treasury
Shares		Accumulated Other
Comprehensive Loss		Total
Equity
(Deficit)
Balance at September 30, 2023$353.1 $490.9 $(998.5)$(112.8)$(267.3)
Net income (loss)— (80.5)— — (80.5)
Other comprehensive income (loss)— — — (8.9)(8.9)
Share-based compensation11.7 — — — 11.7 
Dividends declared ($0.66 per share)
— (38.0)— — (38.0)
Treasury share purchases— — (3.1)— (3.1)
Treasury share issuances(15.2)— 15.9 — 0.7 
Balance at December 30, 2023349.6 372.4 (985.7)(121.7)(385.4)
Net income (loss)— 157.5 — — 157.5 
Other comprehensive income (loss)— — — 3.0 3.0 
Share-based compensation12.4 — — — 12.4 
Dividends declared ($0.66 per share)
— (38.1)— — (38.1)
Treasury share purchases— — (1.7)— (1.7)
Treasury share issuances(8.3)— 9.6 — 1.3 
Balance at March 30, 2024$353.7 $491.8 $(977.8)$(118.6)$(250.9)
The sum of the components may not equal due to rounding.
Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss (“AOCL”) by component were as follows for each of the periods indicated:
Three Months Ended
Foreign Currency
Translation Adjustments		Net Unrealized Gain (Loss)
On Derivative Instruments		Net Unrealized Loss
On Securities		Pension and Other Post-Retirement
Benefit Adjustments		Accumulated Other
Comprehensive Income (Loss)
Balance at December 28, 2024$(27.1)$8.9 $(14.4)$(72.2)$(104.8)
Other comprehensive income (loss) before reclassifications1.0 (1.9)— — (0.9)
Amounts reclassified from accumulated other comprehensive net income (loss)— (3.0)— (2.7)(5.7)
Income tax benefit (expense)— 1.3 — 1.3 2.6 
Net current period other comprehensive income (loss)1.0 (3.6)— (1.4)(4.0)
Balance at March 29, 2025$(26.1)$5.3 $(14.4)$(73.6)$(108.8)
Balance at December 30, 2023$(18.8)$10.4 $(39.5)$(73.8)$(121.7)
Other comprehensive income (loss) before reclassifications(2.6)8.2 (0.6)— 5.0 
Amounts reclassified from accumulated other comprehensive net income (loss)— (1.2)— 1.6 0.4 
Income tax benefit (expense)— (1.8)— (0.6)(2.4)
Net current period other comprehensive income (loss)(2.6)5.2 (0.6)1.0 3.0 
Balance at March 30, 2024$(21.4)$15.7 $(40.1)$(72.9)$(118.6)
The sum of the components may not equal due to rounding.
Six Months Ended
Foreign Currency
Translation Adjustments		Net Unrealized Gain (Loss)
On Derivative Instruments		Net Unrealized Loss
On Securities		Pension and Other Post-Retirement
Benefit Adjustments		Accumulated Other
Comprehensive Income (Loss)
Balance at September 30, 2024$(21.3)$4.9 $(14.4)$(76.5)$(107.3)
Other comprehensive income (loss) before reclassifications(4.9)5.8 — — 0.9 
Amounts reclassified from accumulated other comprehensive net income (loss)— (5.1)— 5.4 0.3 
Income tax benefit (expense)— (0.2)— (2.5)(2.7)
Net current period other comprehensive income (loss)(4.9)0.5 — 2.9 (1.5)
Balance at March 29, 2025$(26.1)$5.3 $(14.4)$(73.6)$(108.8)
Balance at September 30, 2023$(21.9)$20.1 $(38.6)$(72.4)$(112.8)
Other comprehensive income (loss) before reclassifications0.5 (2.8)(1.5)— (3.8)
Amounts reclassified from accumulated other comprehensive net income (loss)— (3.2)— (0.5)(3.7)
Income tax benefit (expense)— 1.5 — 0.1 1.6 
Net current period other comprehensive income (loss)0.5 (4.5)(1.5)(0.4)(5.9)
Balance at March 30, 2024$(21.4)$15.7 $(40.1)$(72.9)$(118.6)
The sum of the components may not equal due to rounding.
Share-Based Awards
Total share-based compensation was as follows for each of the periods indicated:
Three Months EndedSix Months Ended
March 29,
2025		March 30,
2024		March 29,
2025		March 30,
2024
Share-based compensation$22.6 $28.1 $40.0 $44.1 
Related tax benefit recognized4.2 4.6 6.8 7.2 
Stock Options
Stock option activity was as follows:
No. of
Options		Wtd. Avg.
Exercise Price		Wtd. Avg.
Remaining Life		Aggregate
Intrinsic Value
Awards outstanding at September 30, 20242,377,672 $65.03 7.5 years
Granted475,464 72.41 
Exercised(153,383)59.67 
Forfeited(156,084)65.98 
Awards outstanding at March 29, 20252,543,669 66.71 7.8 years$5.5 
Exercisable476,500 110.49 4.6 years0.2 
The weighted-average fair value per share of each option granted during the six months ended March 29, 2025 and March 30, 2024 was $22.20 and $16.66, respectively. The total intrinsic value of options exercised during the six months ended March 29, 2025 and March 30, 2024 was not material. As of March 29, 2025, there was $10.5 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options that is expected to be recognized over a weighted-average period of 2.0 years. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $10.0 and $1.7 for the six months ended March 29, 2025 and March 30, 2024, respectively.
The weighted average assumptions used in the estimation of fair value for awards granted during the six months ended March 29, 2025 are as follows:
Expected volatility39.6 %
Risk-free interest rate4.2 %
Expected dividend yield3.3 %
Expected life6.1 years
Restricted share-based awards
Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows: 
No. of
Units		Wtd. Avg. Grant Date
Fair Value per Unit
Awards outstanding at September 30, 2024766,384 $68.54 
Granted317,412 74.21 
Vested(646,196)74.72 
Forfeited(12,323)71.13 
Awards outstanding at March 29, 2025425,277 63.31 
The weighted-average grant-date fair value of restricted share-based awards granted during the six months ended March 29, 2025 and March 30, 2024 was $74.21 and $49.78 per share, respectively. As of March 29, 2025, there was $8.1 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share-based awards that is expected to be recognized over a weighted-average period of 1.5 years. The total fair value of restricted share-based awards vested during the six months
For fiscal 2025, the Company is granting short-term equity incentive compensation awards to certain associates in the form of restricted share-based award units in lieu of cash-based annual incentive awards. The program is structured so the fiscal 2025 incentive grant, if any, will be made on or near the incentive payout date, subject to certain performance conditions and a service requirement. The number of restricted share-based award units that are ultimately issued to participating associates will be determined based on the incentive payout amount determined for each associate converted into a variable number of restricted share-based award units based on the fair value of the Common Shares on the grant date. The awards are classified as liability awards and, as of March 29, 2025, the Company had accrued $9.3 in the “Other current liabilities” line in the Condensed Consolidated Balance Sheets associated with these awards. As of March 29, 2025, there was $11.0 of total unrecognized pre-tax compensation cost related to these nonvested restricted share-based awards that is expected to be recognized over the remainder of fiscal 2025. The units associated with these awards are excluded from the table above.
Performance-based awards
Performance-based award activity was as follows (based on target award amounts):
No. of
Units		Wtd. Avg. Grant Date
Fair Value per Unit
Awards outstanding at September 30, 2024409,430 $86.61 
Granted142,163 72.01 
Forfeited(107,919)114.25 
Awards outstanding at March 29, 2025443,674 75.63 
The weighted-average grant-date fair value of performance-based award units granted during the six months ended March 29, 2025 and March 30, 2024 was $72.01 and $74.95 per share, respectively. As of March 29, 2025, there was $8.2 of total unrecognized pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based award units that is expected to be recognized over a weighted-average period of 2.2 years. The total fair value of performance-based award units vested during the six months ended March 30, 2024 was $10.6.
During the three months ended March 29, 2025, the Company granted performance-based award units with a three year vesting period that include a performance target based on the Company’s absolute total shareholder return, among other financial targets. Details of the assumptions used in the estimation of fair value for these awards are as follows:
Expected volatility38.6 %
Risk-free interest rate4.2 %